Dr. Abbey Receives 2026 Achievement Award from the American Academy of Ophthalmology
Texas Retina’s Ashkan M. Abbey, MD, has earned the 2026 Achievement Award from the American Academy of Ophthalmology (AAO) in recognition of his contributions to the Academy, its scientific and educational programs,
read more
Dr. Abbey Discusses the Use of VABYSMO® for Polypoidal Choroidal Vasculopathy
In the current issue of Ocular Surgery News on Healio, Texas Retina’s Ashkan M. Abbey, MD, shares his perspective on the recently reported two-year results from the Phase 3b/4 SALWEEN study evaluating
read more
Dr. Choi Develops New Surgical Technique for Macular Holes That Fail to Close After Initial Surgery
Texas Retina’s Rene Y. Choi, MD, PhD, recently published a case report in the medical journal Retinal Cases & Brief Reports describing a surgical technique he developed to treat macular holes that
read more
September is Sports Eye Safety Month
According to Prevent Blindness, there were more than 44,000 sports-related eye injuries treated in the United States in 2025. Basketball had the highest rate of eye injuries for those ages 15 and
read more
Texas Retina Dallas Research Team Recognized for Highest Site Enrollment Globally in Geographic Atrophy Clinical Trial
Under the leadership of Principal Investigator Dr. Ashkan M. Abbey, the Texas Retina Dallas research team was recently named the top enroller for Part I of the DFI18231 study, which is evaluating
read more
Offices Closed for Labor Day on 9/7/26
All Texas Retina offices will be closed on Monday, September 7, 2026, in observance of Labor Day. We wish everyone a safe and happy holiday weekend!
read more
Texas Retina’s Anna Brown Selected for Trials InSight Research Coordinator Executive Committee
Texas Retina Clinical Research Coordinator Anna Brown was recently selected by Trials InSight to serve on its new Research Coordinator Executive Committee. Trials InSight is a first-of-its-kind congress focused on the future
read more

